| SJS/TEN 2017: building multidisciplinary networks to drive science and translation KD White, R Abe, M Ardern-Jones, T Beachkofsky, C Bouchard, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 38-69, 2018 | 131 | 2018 |
| A dimorphic fungus causing disseminated infection in South Africa C Kenyon, K Bonorchis, C Corcoran, G Meintjes, M Locketz, R Lehloenya, ... New England Journal of Medicine 369 (15), 1416-1424, 2013 | 126 | 2013 |
| Controversies in drug allergy: testing for delayed reactions EJ Phillips, P Bigliardi, AJ Bircher, A Broyles, YS Chang, WH Chung, ... Journal of Allergy and Clinical Immunology 143 (1), 66-73, 2019 | 120 | 2019 |
| Dermatologic manifestations of the immune reconstitution inflammatory syndrome R Lehloenya, G Meintjes Dermatologic clinics 24 (4), 549-570, 2006 | 110 | 2006 |
| Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa K Shean, E Streicher, E Pieterson, G Symons, R van Zyl Smit, G Theron, ... PloS one 8 (5), e63057, 2013 | 108 | 2013 |
| Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice JG Peter, R Lehloenya, S Dlamini, K Risma, KD White, KC Konvinse, ... The Journal of Allergy and Clinical Immunology: In Practice 5 (3), 547-563, 2017 | 105 | 2017 |
| Cutaneous adverse drug reactions to anti-tuberculosis drugs: state of the art and into the future RJ Lehloenya, K Dheda Expert review of anti-infective therapy 10 (4), 475-486, 2012 | 76 | 2012 |
| Clinical characteristics, diagnosis, management, and outcomes of disseminated emmonsiosis: a retrospective case series IS Schwartz, NP Govender, C Corcoran, S Dlamini, H Prozesky, R Burton, ... Clinical Infectious Diseases 61 (6), 1004-1012, 2015 | 68 | 2015 |
| Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions RJ Lehloenya, G Todd, M Badri, K Dheda The International journal of tuberculosis and lung disease 15 (12), 1649-1657, 2011 | 61 | 2011 |
| In vivo molecular dissection of the effects of HIV-1 in active tuberculosis LCK Bell, G Pollara, M Pascoe, GS Tomlinson, RJ Lehloenya, J Roe, ... PLoS pathogens 12 (3), e1005469, 2016 | 44 | 2016 |
| Diagnostic patch testing following tuberculosis‐associated cutaneous adverse drug reactions induces systemic reactions in HIV‐infected persons RJ Lehloenya, G Todd, J Wallace, MR Ngwanya, R Muloiwa, K Dheda British Journal of Dermatology 175 (1), 150-156, 2016 | 42 | 2016 |
| Severe recurrence of drug rash with eosinophilia and systemic symptoms syndrome secondary to rifampicin patch testing in a human immunodeficiency virus-infected man K Shebe, MR Ngwanya, N Gantsho, RJ Lehloenya Contact Dermatitis 70 (2), 125-127, 2014 | 37 | 2014 |
| AIDS-related endemic mycoses in Western Cape, South Africa, and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions IS Schwartz, C Kenyon, R Lehloenya, S Claasens, Z Spengane, ... Open forum infectious diseases 4 (4), ofx186, 2017 | 36 | 2017 |
| Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test GS Tomlinson, TJ Cashmore, PTG Elkington, J Yates, RJ Lehloenya, ... European journal of immunology 41 (11), 3253-3260, 2011 | 34 | 2011 |
| SJS/TEN 2019: from science to translation WC Chang, R Abe, P Anderson, W Anderson, MR Ardern-Jones, ... Journal of dermatological science 98 (1), 2-12, 2020 | 31 | 2020 |
| Applications of immunopharmacogenomics: predicting, preventing, and understanding immune-mediated adverse drug reactions JH Karnes, MA Miller, KD White, KC Konvinse, RK Pavlos, AJ Redwood, ... Annual review of pharmacology and toxicology 59, 463-486, 2019 | 31 | 2019 |
| Drug hypersensitivity in HIV infection J Peter, P Choshi, RJ Lehloenya Current opinion in allergy and clinical immunology 19 (4), 272, 2019 | 29 | 2019 |
| Factors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysis L Knight, R Muloiwa, S Dlamini, RJ Lehloenya PLoS One 9 (4), e93543, 2014 | 29 | 2014 |
| Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients RJ Lehloenya, J Wallace, G Todd, K Dheda The International journal of tuberculosis and lung disease 16 (9), 1260-1264, 2012 | 26 | 2012 |
| Annular erythema and photosensitivity as manifestations of efavirenz-induced cutaneous reactions: a review of five consecutive cases T Isaacs, MR Ngwanya, S Dlamini, RJ Lehloenya Journal of Antimicrobial Chemotherapy 68 (12), 2871-2874, 2013 | 24 | 2013 |
Sipho DlaminiGroote Schuur Hospital, University of Cape TownVerified email at uct.ac.za
